Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Electrolyte disturbances with HIV infection

Richard H Sterns, MD
Section Editor
Michael Emmett, MD
Deputy Editor
Albert Q Lam, MD


Hyponatremia and hyperkalemia are the two major electrolyte disorders that may be associated with HIV infection. They are more likely to occur in sicker patients, with the highest rates in those who are hospitalized. In addition, lactic acidosis, hypophosphatemia have been described.

The major electrolyte disorders that occur in patients with HIV infection will be reviewed here. A discussion of the endocrine changes seen in these patients is presented separately. (See "Pituitary and adrenal gland dysfunction in HIV-infected patients".)


Hyponatremia occurs in as many as 35 to 55 percent of hospitalized HIV-infected patients, but it can also be seen in ambulatory patients [1-3]. The hyponatremia is usually due to one or more of three disorders, each of which is associated with an impaired ability to excrete water due to increased release of antidiuretic hormone (ADH): syndrome of inappropriate ADH secretion (SIADH), volume depletion, and adrenal insufficiency.

Syndrome of inappropriate ADH secretion — The syndrome of inappropriate ADH secretion (SIADH) is usually due to pneumonia (with Pneumocystis carinii or other organisms), malignancy, or occult or symptomatic infection of the central nervous system [1-3]. Among patients treated with intravenous trimethoprim-sulfamethoxazole, the fluid required to dilute the drug may contribute to the development of hyponatremia. (See "Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)".)

Volume depletion — Volume depletion in HIV-infected patients is most often caused by gastrointestinal fluid losses, primarily from diarrhea [1,3]. Hypovolemia can be distinguished from the SIADH by a low urine sodium concentration (usually below 15 meq/L) and correction of the hyponatremia with volume repletion. (See "Diagnostic evaluation of adults with hyponatremia".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Oct 2017. | This topic last updated: Jan 04, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Glassock RJ, Cohen AH, Danovitch G, Parsa KP. Human immunodeficiency virus (HIV) infection and the kidney. Ann Intern Med 1990; 112:35.
  2. Vitting KE, Gardenswartz MH, Zabetakis PM, et al. Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome. JAMA 1990; 263:973.
  3. Tang WW, Kaptein EM, Feinstein EI, Massry SG. Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex. Am J Med 1993; 94:169.
  4. Kalin MF, Poretsky L, Seres DS, Zumoff B. Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome. Am J Med 1987; 82:1035.
  5. Guy RJ, Turberg Y, Davidson RN, et al. Mineralocorticoid deficiency in HIV infection. BMJ 1989; 298:496.
  6. Choi MJ, Fernandez PC, Patnaik A, et al. Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med 1993; 328:703.
  7. Greenberg S, Reiser IW, Chou SY, Porush JG. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Intern Med 1993; 119:291.
  8. Velázquez H, Perazella MA, Wright FS, Ellison DH. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med 1993; 119:296.
  9. Lachaal M, Venuto RC. Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine. Am J Med 1989; 87:260.
  10. Kleyman TR, Roberts C, Ling BN. A mechanism for pentamidine-induced hyperkalemia: inhibition of distal nephron sodium transport. Ann Intern Med 1995; 122:103.
  11. Preston RA, Hirsh MJ MD, Oster MD Jr, Oster HR MD. University of Miami Division of Clinical Pharmacology therapeutic rounds: drug-induced hyperkalemia. Am J Ther 1998; 5:125.
  12. Chattha G, Arieff AI, Cummings C, Tierney LM Jr. Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118:37.
  13. Isnard Bagnis C, Du Montcel ST, Fonfrede M, et al. Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART era. Nephron Physiol 2006; 103:p131.